Huaiwen Chen

1.4k total citations
31 papers, 1.2k citations indexed

About

Huaiwen Chen is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Huaiwen Chen has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Biomaterials and 8 papers in Oncology. Recurrent topics in Huaiwen Chen's work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (11 papers) and Cancer Cells and Metastasis (6 papers). Huaiwen Chen is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (11 papers) and Cancer Cells and Metastasis (6 papers). Huaiwen Chen collaborates with scholars based in China, Taiwan and India. Huaiwen Chen's co-authors include Jie Gao, Yajun Guo, Weizhu Qian, Jianxin Dai, Yongsheng Yu, Bohua Li, Yu Xia, Zuochong Yu, Geng Kou and Yingying Zhang and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and Journal of Controlled Release.

In The Last Decade

Huaiwen Chen

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaiwen Chen China 20 657 564 437 222 118 31 1.2k
Huining He China 19 573 0.9× 530 0.9× 499 1.1× 124 0.6× 112 0.9× 44 1.3k
Michael Teifel Germany 15 602 0.9× 483 0.9× 300 0.7× 222 1.0× 89 0.8× 34 1.1k
Paula Ofek Israel 18 661 1.0× 400 0.7× 319 0.7× 224 1.0× 98 0.8× 27 1.2k
Alexandros Marios Sofias Germany 17 494 0.8× 447 0.8× 505 1.2× 135 0.6× 164 1.4× 32 1.2k
Tingting Lin China 12 467 0.7× 409 0.7× 373 0.9× 206 0.9× 151 1.3× 47 1.1k
Hongyue Jin China 10 557 0.8× 513 0.9× 459 1.1× 171 0.8× 215 1.8× 10 1.2k
Andrew Satterlee United States 13 628 1.0× 369 0.7× 425 1.0× 200 0.9× 161 1.4× 29 1.2k
Shiyan Dong China 20 744 1.1× 360 0.6× 359 0.8× 123 0.6× 182 1.5× 34 1.3k
Xinghai Li United States 23 629 1.0× 775 1.4× 432 1.0× 166 0.7× 116 1.0× 36 1.5k
Aeju Lee South Korea 23 681 1.0× 401 0.7× 569 1.3× 160 0.7× 101 0.9× 38 1.4k

Countries citing papers authored by Huaiwen Chen

Since Specialization
Citations

This map shows the geographic impact of Huaiwen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaiwen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaiwen Chen more than expected).

Fields of papers citing papers by Huaiwen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaiwen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaiwen Chen. The network helps show where Huaiwen Chen may publish in the future.

Co-authorship network of co-authors of Huaiwen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Huaiwen Chen. A scholar is included among the top collaborators of Huaiwen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaiwen Chen. Huaiwen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Guanghao, et al.. (2023). Integrated radiochemotherapy study of ZIF-8 coated with osteosarcoma-platelet hybrid membranes for the delivery of Dbait and Adriamycin. Frontiers in Bioengineering and Biotechnology. 11. 1147064–1147064. 9 indexed citations
2.
Zhang, Fulei, Yi Hou, Minhui Zhu, et al.. (2021). Death Pathways of Cancer Cells Modulated by Surface Molecule Density on Gold Nanorods. Advanced Science. 8(22). e2102666–e2102666. 21 indexed citations
3.
Chen, Xiaohong, et al.. (2019). <p>Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy</p>. International Journal of Nanomedicine. Volume 14. 6357–6369. 30 indexed citations
4.
Chen, Fangyi, Xiaoxia Qi, Yanchao Chen, et al.. (2018). Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells. Nanomedicine Nanotechnology Biology and Medicine. 14(7). 2115–2127. 60 indexed citations
5.
Zeng, Yibin, Zuochong Yu, Yanni He, et al.. (2017). Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells. Acta Pharmacologica Sinica. 39(2). 261–274. 45 indexed citations
6.
Tian, Bing, Ri Liu, Shiyue Chen, et al.. (2017). Mannose-coated gadolinium liposomes for improved magnetic resonance imaging in acute pancreatitis. International Journal of Nanomedicine. Volume 12. 1127–1141. 15 indexed citations
7.
Jiang, Jianxin, Huaiwen Chen, Chao Yu, et al.. (2015). The Promotion of Salinomycin Delivery to Hepatocellular Carcinoma Cells Through EGFR and CD133 Aptamers Conjugation by PLGA Nanoparticles. Nanomedicine. 10(12). 1863–1879. 44 indexed citations
8.
Yu, Zuochong, et al.. (2015). Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells. International Journal of Nanomedicine. 10. 2537–2537. 102 indexed citations
9.
Su, Xiao, Hao Song, Kaixuan Yang, et al.. (2015). Co-Delivery of Doxorubicin and PEGylated C16-Ceramide by Nanoliposomes for Enhanced Therapy Against Multidrug Resistance. Nanomedicine. 10(13). 2033–2050. 35 indexed citations
10.
Gao, Jie, Huaiwen Chen, Yongsheng Yu, et al.. (2013). Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA. Biomaterials. 34(38). 10084–10098. 77 indexed citations
11.
Gao, Jie, Yu Xia, Huaiwen Chen, et al.. (2013). Polymer–Lipid Hybrid Nanoparticles Conjugated with Anti-EGF Receptor Antibody for Targeted Drug Delivery to Hepatocellular Carcinoma. Nanomedicine. 9(2). 279–293. 71 indexed citations
12.
Li, Wei, He Zhao, Li Zhang, et al.. (2012). Novel Dual-Control Poly( N -Isopropylacrylamide- Co -Chlorophyllin) Nanogels for Improving Drug Release. Nanomedicine. 7(3). 383–392. 25 indexed citations
13.
Gao, Jie, Yongsheng Yu, Yingying Zhang, et al.. (2011). EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials. 33(1). 270–282. 95 indexed citations
14.
15.
Li, Wei, Jinfeng Li, Jie Gao, et al.. (2011). The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors. Biomaterials. 32(15). 3832–3844. 110 indexed citations
16.
Gao, Jie, Geng Kou, Huaiwen Chen, et al.. (2008). Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab′) fragments. Molecular Cancer Therapeutics. 7(10). 3399–3407. 19 indexed citations
17.
Chen, Huaiwen, Jie Gao, Ying Lü, et al.. (2008). Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy. Journal of Controlled Release. 128(3). 209–216. 66 indexed citations
18.
Kou, Geng, Jie Gao, Huaiwen Chen, et al.. (2007). Preparation and Characterization of Paclitaxel-loaded PLGA Nanoparticles Coated with Cationic SM5-1 Single-chain Antibody. BMB Reports. 40(5). 731–739. 36 indexed citations
19.
Kuo, Chung‐Hsien, et al.. (2004). Development of Internet Based Remote Health and Activity Monitoring Systems for the Elders. Journal of Medical and Biological Engineering. 24(1). 57–67. 6 indexed citations
20.
Kuo, Chung‐Hsien, et al.. (2004). Design and implementation of Internet-based in-house healthcare and home automation systems. 3. 2944–2949. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huining He Breakdown of academic impact, for papers by Michael Teifel Breakdown of academic impact, for papers by Paula Ofek Breakdown of academic impact, for papers by Alexandros Marios Sofias Breakdown of academic impact, for papers by Tingting Lin Breakdown of academic impact, for papers by Hongyue Jin Breakdown of academic impact, for papers by Andrew Satterlee Breakdown of academic impact, for papers by Shiyan Dong Breakdown of academic impact, for papers by Xinghai Li Breakdown of academic impact, for papers by Aeju Lee
Rankless by CCL
2026